X4 Pharmaceuticals secures up to $150M debt facility

X4 Pharmaceuticals entered a senior secured term loan facility with K2 HealthVentures totaling up to $150M; $80M funded at closing to repay its prior $75M loan and related fees, with up to $70M additional availability subject to K2HV approval and conditions.